BPC-157: Mechanism, Published Studies and Recovery Applications
The most-studied gastric body peptide in animal models of tissue repair.
What is BPC-157
BPC-157 (Body Protection Compound), 15-amino-acid synthetic peptide from gastric juice protein. Sikiric, 1990s.
Mechanism
- Angiogenesis via VEGFR2.
- Nitric oxide pathway.
- FGF/EGF activation.
- Brain-gut axis.
Key studies
Tendon
Achilles transection: faster collagen organization at 4–6 wk.
Intestine
DSS colitis: reduced ulceration.
Bone
Denser callus at 4 weeks.
Dose ranges
Animal: 10–250 mcg/kg/day. Human self-reported: 250–500 mcg twice daily SC. Descriptive context only.
TB-500 synergy
BPC-157 (angiogenesis) + TB-500 (cell migration) = Wolverine Stack.
vs alternatives
- BPC-157: systemic angiogenesis.
- GHK-Cu: dermal matrix.
- KPV: cutaneous anti-inflammatory.
Related products
About this guide: Educational content for research use (RUO). The scientific perspective is informed by the evidence discussed by Dr. Abud Bakri on the Huberman Lab — this does not imply his endorsement or that of Renova Peptides. Always verify against the primary literature and a qualified professional. Reference: Huberman Lab
⚠ Research use only. Not medical advice.